Figure 2

Network plots of medication strategies of fremanezumab in (A) cumulative 50% reduction rate of migraine, (B) cumulative 75% reduction rate of migraine, (C) reduction of migraine days, (D) treatment related adverse event, and (E) serious adverse event.